T-CELL LYMPHOMA
Clinical trials for T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug shows promise in preventing relapse after transplant
Disease control TerminatedThis study tested a drug called duvelisib in people with T-cell lymphoma who had a stem cell transplant. The goal was to see if taking duvelisib after the transplant could safely help keep the cancer from returning. The study was stopped early, but it involved 17 adults with cert…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Lymphoma drug safety study halted early
Disease control TerminatedThis study looked at the safety of a drug called tazemetostat in people with a rare blood cancer (peripheral T-cell lymphoma) that had returned or stopped responding to other treatments. The study planned to enroll 6 adults and find the best dose with the fewest side effects. How…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 08, 2026 13:09 UTC